p/e 16.5 is far too high. npat growth is negative or flat. even after cost cutting. so future growth is maybe 5% at best. thats not a good growth rate. should be closer to 12 to 13x p/e imho with a dividend in line with the banks. stock is over valued 20% at bottom of range on my numbers. most analysts cite cost cutting, but we should be looking at overall growth, as cost cut gives a temporary boost. there are heaps of risks too - like competitive pressures.
- Forums
- IPOs
- Medibank Prospectus Details
Medibank Prospectus Details, page-81
-
- There are more pages in this discussion • 160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review